Selected research
Market Structure
Global Biocidal Formulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Biocidal Formulation market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Biocidal Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biocidal Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biocidal Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Biocidal Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Biocidal Formulation include Lanxess, Stepan Company, BASF SE, Bayer, Lonza, Ecolab, Solvay, DuPont and Dow Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Biocidal Formulation output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Biocidal Formulation by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Biocidal Formulation market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biocidal Formulation and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biocidal Formulation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biocidal Formulation market size, projected growth trends, production technologies, key applications, and end-use industries.
Biocidal Formulation Segment by Company
Lanxess
Stepan Company
BASF SE
Bayer
Lonza
Ecolab
Solvay
DuPont
Dow Chemical
Clariant
Evonik
Nufarm
Vink Chemicals
Corteva
Seipasa SA
FMC Corporation
Biocidal Formulation Segment by Type
Disinfectants
Preservatives
Others
Biocidal Formulation Segment by Application
Hospitals
Pharmaceuticals
Food and Beverage
Agriculture
Others
Biocidal Formulation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biocidal Formulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biocidal Formulation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biocidal Formulation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Biocidal Formulation market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biocidal Formulation industry.
Chapter 3: Detailed analysis of Biocidal Formulation market competition landscape. Including Biocidal Formulation manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Biocidal Formulation by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Biocidal Formulation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Disinfectants
- Preservatives
- Others
Applications
- Hospitals
- Pharmaceuticals
- Food and Beverage
- Agriculture
- Others
Companies covered
- Lanxess
- Stepan Company
- BASF SE
- Bayer
- Lonza
- Ecolab
- Solvay
- DuPont
- Dow Chemical
- Clariant
- Evonik
- Nufarm
- Vink Chemicals
- Corteva
- Seipasa SA
- FMC Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Biocidal Formulation Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Biocidal Formulation Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Biocidal Formulation Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Biocidal Formulation Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Biocidal Formulation Market Dynamics
- 2.1 Biocidal Formulation Industry Trends
- 2.2 Biocidal Formulation Industry Drivers
- 2.3 Biocidal Formulation Industry Opportunities and Challenges
- 2.4 Biocidal Formulation Industry Restraints
3 Biocidal Formulation Market by Manufacturers
- 3.1 Global Biocidal Formulation Production Value by Manufacturers (2021-2026)
- 3.2 Global Biocidal Formulation Production by Manufacturers (2021-2026)
- 3.3 Global Biocidal Formulation Average Price by Manufacturers (2021-2026)
- 3.4 Global Biocidal Formulation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Biocidal Formulation Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Biocidal Formulation Manufacturers, Product Type & Application
- 3.7 Global Biocidal Formulation Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Biocidal Formulation Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Biocidal Formulation Players Market Share by Production Value in 2025
- 3.8.3 2025 Biocidal Formulation Tier 1, Tier 2, and Tier 3
4 Biocidal Formulation Market by Type
- 4.1 Biocidal Formulation Type Introduction
- 4.1.1 Disinfectants
- 4.1.2 Preservatives
- 4.1.3 Others
- 4.2 Global Biocidal Formulation Production by Type
- 4.2.1 Global Biocidal Formulation Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biocidal Formulation Production by Type (2021-2032)
- 4.2.3 Global Biocidal Formulation Production Market Share by Type (2021-2032)
- 4.3 Global Biocidal Formulation Production Value by Type
- 4.3.1 Global Biocidal Formulation Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Biocidal Formulation Production Value by Type (2021-2032)
- 4.3.3 Global Biocidal Formulation Production Value Market Share by Type (2021-2032)
5 Biocidal Formulation Market by Application
- 5.1 Biocidal Formulation Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Pharmaceuticals
- 5.1.3 Food and Beverage
- 5.1.4 Agriculture
- 5.1.5 Others
- 5.2 Global Biocidal Formulation Production by Application
- 5.2.1 Global Biocidal Formulation Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biocidal Formulation Production by Application (2021-2032)
- 5.2.3 Global Biocidal Formulation Production Market Share by Application (2021-2032)
- 5.3 Global Biocidal Formulation Production Value by Application
- 5.3.1 Global Biocidal Formulation Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Biocidal Formulation Production Value by Application (2021-2032)
- 5.3.3 Global Biocidal Formulation Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Lanxess
- 6.1.1 Lanxess Company Information
- 6.1.2 Lanxess Business Overview
- 6.1.3 Lanxess Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.1.4 Lanxess Biocidal Formulation Product Portfolio
- 6.1.5 Lanxess Recent Developments
- 6.2 Stepan Company
- 6.2.1 Stepan Company Company Information
- 6.2.2 Stepan Company Business Overview
- 6.2.3 Stepan Company Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.2.4 Stepan Company Biocidal Formulation Product Portfolio
- 6.2.5 Stepan Company Recent Developments
- 6.3 BASF SE
- 6.3.1 BASF SE Company Information
- 6.3.2 BASF SE Business Overview
- 6.3.3 BASF SE Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.3.4 BASF SE Biocidal Formulation Product Portfolio
- 6.3.5 BASF SE Recent Developments
- 6.4 Bayer
- 6.4.1 Bayer Company Information
- 6.4.2 Bayer Business Overview
- 6.4.3 Bayer Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.4.4 Bayer Biocidal Formulation Product Portfolio
- 6.4.5 Bayer Recent Developments
- 6.5 Lonza
- 6.5.1 Lonza Company Information
- 6.5.2 Lonza Business Overview
- 6.5.3 Lonza Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.5.4 Lonza Biocidal Formulation Product Portfolio
- 6.5.5 Lonza Recent Developments
- 6.6 Ecolab
- 6.6.1 Ecolab Company Information
- 6.6.2 Ecolab Business Overview
- 6.6.3 Ecolab Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.6.4 Ecolab Biocidal Formulation Product Portfolio
- 6.6.5 Ecolab Recent Developments
- 6.7 Solvay
- 6.7.1 Solvay Company Information
- 6.7.2 Solvay Business Overview
- 6.7.3 Solvay Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.7.4 Solvay Biocidal Formulation Product Portfolio
- 6.7.5 Solvay Recent Developments
- 6.8 DuPont
- 6.8.1 DuPont Company Information
- 6.8.2 DuPont Business Overview
- 6.8.3 DuPont Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.8.4 DuPont Biocidal Formulation Product Portfolio
- 6.8.5 DuPont Recent Developments
- 6.9 Dow Chemical
- 6.9.1 Dow Chemical Company Information
- 6.9.2 Dow Chemical Business Overview
- 6.9.3 Dow Chemical Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.9.4 Dow Chemical Biocidal Formulation Product Portfolio
- 6.9.5 Dow Chemical Recent Developments
- 6.10 Clariant
- 6.10.1 Clariant Company Information
- 6.10.2 Clariant Business Overview
- 6.10.3 Clariant Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.10.4 Clariant Biocidal Formulation Product Portfolio
- 6.10.5 Clariant Recent Developments
- 6.11 Evonik
- 6.11.1 Evonik Company Information
- 6.11.2 Evonik Business Overview
- 6.11.3 Evonik Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.11.4 Evonik Biocidal Formulation Product Portfolio
- 6.11.5 Evonik Recent Developments
- 6.12 Nufarm
- 6.12.1 Nufarm Company Information
- 6.12.2 Nufarm Business Overview
- 6.12.3 Nufarm Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.12.4 Nufarm Biocidal Formulation Product Portfolio
- 6.12.5 Nufarm Recent Developments
- 6.13 Vink Chemicals
- 6.13.1 Vink Chemicals Company Information
- 6.13.2 Vink Chemicals Business Overview
- 6.13.3 Vink Chemicals Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.13.4 Vink Chemicals Biocidal Formulation Product Portfolio
- 6.13.5 Vink Chemicals Recent Developments
- 6.14 Corteva
- 6.14.1 Corteva Company Information
- 6.14.2 Corteva Business Overview
- 6.14.3 Corteva Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.14.4 Corteva Biocidal Formulation Product Portfolio
- 6.14.5 Corteva Recent Developments
- 6.15 Seipasa SA
- 6.15.1 Seipasa SA Company Information
- 6.15.2 Seipasa SA Business Overview
- 6.15.3 Seipasa SA Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.15.4 Seipasa SA Biocidal Formulation Product Portfolio
- 6.15.5 Seipasa SA Recent Developments
- 6.16 FMC Corporation
- 6.16.1 FMC Corporation Company Information
- 6.16.2 FMC Corporation Business Overview
- 6.16.3 FMC Corporation Biocidal Formulation Production, Value and Gross Margin (2021-2026)
- 6.16.4 FMC Corporation Biocidal Formulation Product Portfolio
- 6.16.5 FMC Corporation Recent Developments
7 Global Biocidal Formulation Production by Region
- 7.1 Global Biocidal Formulation Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Biocidal Formulation Production by Region (2021-2032)
- 7.2.1 Global Biocidal Formulation Production by Region (2021-2026)
- 7.2.2 Global Biocidal Formulation Production Forecast by Region (2027-2032)
- 7.3 Global Biocidal Formulation Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Biocidal Formulation Production Value by Region (2021-2032)
- 7.4.1 Global Biocidal Formulation Production Value by Region (2021-2026)
- 7.4.2 Global Biocidal Formulation Production Value by Region (2027-2032)
- 7.5 Global Biocidal Formulation Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Biocidal Formulation Production Value (2021-2032)
- 7.6.2 Europe Biocidal Formulation Production Value (2021-2032)
- 7.6.3 Asia-Pacific Biocidal Formulation Production Value (2021-2032)
- 7.6.4 South America Biocidal Formulation Production Value (2021-2032)
- 7.6.5 Middle East & Africa Biocidal Formulation Production Value (2021-2032)
8 Global Biocidal Formulation Consumption by Region
- 8.1 Global Biocidal Formulation Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Biocidal Formulation Consumption by Region (2021-2032)
- 8.2.1 Global Biocidal Formulation Consumption by Region (2021-2026)
- 8.2.2 Global Biocidal Formulation Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Biocidal Formulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Biocidal Formulation Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Biocidal Formulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Biocidal Formulation Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Biocidal Formulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Biocidal Formulation Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Biocidal Formulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Biocidal Formulation Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Biocidal Formulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Biocidal Formulation Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Biocidal Formulation Value Chain Analysis
- 9.1.1 Biocidal Formulation Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Biocidal Formulation Production Mode & Process
- 9.2 Biocidal Formulation Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Biocidal Formulation Distributors
- 9.2.3 Biocidal Formulation Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst